Increase/Decrease in Cash (Annual)

Increase/Decrease in Cash: The total change in cash for the company over the given period.

AbbVie Inc. (ABBV) had Increase/Decrease in Cash of $-7.29B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$56.33B
Net Income	$4.24B
Cost of Goods Sold	$16.90B
Gross Profit	$39.43B
Operating Expenses	$47.20B
Operating Income	$9.14B
Non-Operating Income/Expense	$-5.42B
Pre-Tax Income	$3.72B
Normalized Pre-Tax Income	$3.72B
Income after Taxes	$4.29B
Income from Continuous Operations	$4.29B
Consolidated Net Income/Loss	$4.29B
Normalized Income after Taxes	$4.29B
EBIT	$9.14B
EBITDA	$17.52B
Weighted-Average Shares Outstanding (Basic)	1.77B
Weighted-Average Shares Outstanding (Diluted)	1.77B
Earnings per Share (EPS) (Basic)	$2.40
Earnings per Share (EPS) (Diluted)	$2.39
Balance Sheet Financials
Current Assets	$25.58B
Property, Plant, and Equipment	$5.13B
Long-Term Assets	$109.58B
Total Assets	$135.16B
Current Liabilities	$38.75B
Long-Term Debt	$60.34B
Long-Term Liabilities	$93.05B
Total Liabilities	$131.80B
Common Equity	$3.36B
Tangible Shareholders Equity	$-91.66B
Shareholders Equity	$3.36B
Common Shares Outstanding	1.77B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$18.81B
Cash Flow from Investing Activities	$-20.82B
Cash Flow from Financial Activities	$-5.21B
Beginning Cash	$12.81B
End Cash	$5.52B
Increase/Decrease in Cash	$-7.29B
Stock-Based Compensation	$911.00M
Common Stock Dividends Paid	$-11.03B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.66
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.95
Debt to Equity Ratio	19.96
Gross Margin	69.99%
Operating Margin	16.22%
EBIT Margin	16.22%
EBITDA Margin	31.11%
Pre-Tax Profit Margin	6.60%
Profit Margin	7.52%
Free Cash Flow	$17.83B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.42
Inventory Turnover	4.04
Receiveable Turnover	5.16
Days Sales in Receivables	70.75
Return on Equity	127.41%
Return on Tangible Equity	-4.68%
Return on Assets	3.17%
Return on Investments	6.73%
Book Value Per Share	$1.91
Free Cash Flow per Share	$10.06
Operating Cash Flow per Share	$10.61

Data from Zacks Investment Research, Inc.